New Data Demonstrates Abbott’s Investigational MitraClip(R) System Has Potential to be a Valuable Treatment Option for Patients With Mitral Regurgitation, the Most Common Heart Valve Condition

First-of-its-Kind, Catheter-Based Device for Mitral Valve Repair Meets Both Primary Safety and Effectiveness Endpoints Compared to Surgery

ATLANTA, March 14, 2010 – Late-breaking data presented today at the American College of
Cardiology's 59th annual scientific session from the landmark EVEREST II
(Endovascular Valve Edge-to-Edge REpair STudy) trial demonstrated that
Abbott's investigational MitraClip(R) system met both its primary safety [...]